Technologies

Medical Sciences

Title:

Recombinant Streptokinase (rSK)-CSIR's Second- Generation Clot Buster

Area:

Medical Sciences

Focus Area:

Manufacturing of Streptokinase

Social Benefits:

1. Cost effective. 2. More efficent than natural streptokinase

Developing Agency:

CSIR-Institute of Microbial Technology (IMT), Chandigarh

Technology Readiness Index:

Market Launch

Email:

director@imtech.res.in
Website Link :http://www.imtech.res.in
Source (more info) :https://t.ly/l_sb

Brief Description

Description :

Developed a facile process to manufacture a recombinant version of natural type streptokinase which is roughly ten times efficient as the natural SK production technology.

Related Technologies